Fundings for medical technologies thus far in March 2015 stand at $542 million, led by the $57 million funding of EndoChoice, Inc.
Below are the top fundings for the month.
|EndoChoice, Inc., has raised $57 million in a round of funding, according to the company||Endoscopes and other instrumentation in gastroenterology|
|Apollo Endosurgery, Inc., has closed a $50 million secured term loan according to the company||Minimally invasive endoscopic surgical products for bariatric and gastrointestinal procedures|
|Semma Therapeutics has raised $44 million in a Series A round of funding according to the company||Cell therapy for type I diabetes|
|Svelte Medical Systems, Inc., has raised $38.01 million of a planned $48.74 million round of funding according to a regulatory filing||Drug eluting and other coronary stents|
|Auxogyn, Inc., has raised $34.32 million of a planned $40 million round of funding according to a regulatory filing||Diagnostic and other technologies focused on women’s reproductive health|
|SteadyMed Therapeutics, Inc., has raised $39.95 million in its IPO according to press reports||Patch-pump drug delivery technology|
|Hansen Medical, Inc., has raised $35 million in a round of funding according to a regulatory filing||Intravascular robotics|
For the complete list of medtech fundings in March 2015, see link.
For a historical list of the individual fundings in medtech, by month, since 2009, see link.